They said it at DeviceTalks Boston

David Neustaedter is Medtronic’s VP of venture investments [Photo courtesy of Medtronic]

VENTURE CAPITAL

David Neustaedter, VP of venture capital at Medtronic

Neustaedter, discussed how the COVID-19 pandemic’s challenges accelerated trends that influence how Medtronic views potential investments: “Payers, physicians, all the stakeholders that we care about had to become a little more flexible, and some of that flexibility is likely to pass the test of time. So that’s tremendous in that regard,” he said. “I think there are some other challenges that look to persist. For example, we see a lot of staffing issues. It’s really slowing things down. … [There’s a] move toward more information captured, whether it’s remotely or acutely and being able to be accessed and the ability, for example, to modulate therapeutic dose or call a patient in early, just like you would a BMW with a loose fan belt these days. And I think there’s a lot more predictive and information capability being added into almost every device that’s implanted and some of the devices that can be used intraoperatively.”

Read more: Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’

Next >>